S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 reasons to buy AMD before 2024
How does the Consumer Price Index affect the stock market?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Generative AI boosts UiPath; analysts see triple-digit EPS growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Broadcom falls into a buy-the-dip opportunity 
Closing prices for crude oil, gold and other commodities
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 reasons to buy AMD before 2024
How does the Consumer Price Index affect the stock market?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Generative AI boosts UiPath; analysts see triple-digit EPS growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Broadcom falls into a buy-the-dip opportunity 
Closing prices for crude oil, gold and other commodities
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 reasons to buy AMD before 2024
How does the Consumer Price Index affect the stock market?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Generative AI boosts UiPath; analysts see triple-digit EPS growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Broadcom falls into a buy-the-dip opportunity 
Closing prices for crude oil, gold and other commodities
S&P 500   4,604.37
DOW   36,247.87
QQQ   392.17
10 e-commerce stocks to consider for long-term buys
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 reasons to buy AMD before 2024
How does the Consumer Price Index affect the stock market?
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
3 biotech powerhouses poised to thrive amid sector rebound
Generative AI boosts UiPath; analysts see triple-digit EPS growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Broadcom falls into a buy-the-dip opportunity 
Closing prices for crude oil, gold and other commodities

IRIDEX (IRIX) Stock Forecast & Price Target

$2.76
+0.02 (+0.73%)
(As of 12/8/2023 ET)
Compare
Today's Range
$2.72
$2.80
50-Day Range
$1.90
$3.28
52-Week Range
$1.31
$3.48
Volume
39,286 shs
Average Volume
85,018 shs
Market Capitalization
$44.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00

IRIDEX Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

N/A
Based on 0 Analyst Ratings

Analysts' Consensus Price Target

$2.00
-27.54% Downside
High Forecast$2.00
Average Forecast$2.00
Low Forecast$2.00
TypeCurrent Forecast
12/9/22 to 12/9/23
1 Month Ago
11/9/22 to 11/9/23
3 Months Ago
9/10/22 to 9/10/23
1 Year Ago
12/9/21 to 12/9/22
Consensus RatingN/AN/AN/A
Hold
Strong Buy N/A N/A N/A
0 Strong Buy rating(s)
Buy N/A N/A N/A
0 Buy rating(s)
Hold N/A N/A N/A
1 Hold rating(s)
Sell N/A N/A N/A
0 Sell rating(s)
Consensus Price Target$2.00$2.00$2.00$3.00
Predicted Upside-27.54% Downside2.56% Upside2.56% Upside5.08% Upside
Get IRIDEX Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for IRIX and its competitors with MarketBeat's FREE daily newsletter.


IRIX Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

IRIX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

IRIDEX Stock vs. The Competition

TypeIRIDEXComputer and Technology CompaniesS&P 500
Consensus Rating Score
0.00
2.56
2.49
Consensus RatingN/AModerate BuyHold
Predicted Upside-27.54% Downside185.58% Upside3,819.08% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/11/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$3.00 ➝ $2.00+2.56%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 07:17 AM ET.












IRIX Price Target - Frequently Asked Questions

Does IRIDEX's stock price have much upside?

According to analysts, IRIDEX's stock has a predicted upside of 2.56% based on their 12-month stock forecasts.


Stock Ratings Reports and Tools

This page (NASDAQ:IRIX) was last updated on 12/9/2023 by MarketBeat.com Staff

My Account -